INSPIRE Continuation Post-Approval Study

CompletedOBSERVATIONAL
Enrollment

220

Participants

Timeline

Start Date

June 30, 2019

Primary Completion Date

October 12, 2021

Study Completion Date

October 12, 2021

Conditions
Bronchiolitis Obliterans
Interventions
DEVICE

OCS Lung System

No active interventions are part of this study. This study will collect long-term survival and BOS data in subjects who were part of the INSPIRE trial.

Trial Locations (17)

2010

St. Vincent's Hospital, Darlinghurst

3000

University of Leuven Hospital, Leuven

15213

University of Pittsburgh Medical Center, Pittsburgh

25222

Hospital Universitario Puerta De Hierro, Madrid

35128

University of Padua, Padua

46202

Indiana University, Indianapolis

55455

University of Minnesota, Minneapolis

67091

N.H.C Hospital Civil, Strasbourg

85013

St. Joseph's Hospital and Medical Center, Phoenix

90095

UCLA Medical Center, Los Angeles

94143

University of California at San Francisco, San Francisco

02114

Massachusetts General Hospital, Boston

T6G 2C8

University of Alberta, Edmonton

D-13353

German Heart Institute Berlin, Berlin

D-300625

Hannover Medical School, Hanover

CB23 3RE

Papworth Hospital, Cambridge

UB9 6JH

Harefield Hospital, Middlesex

Sponsors

Lead Sponsor

All Listed Sponsors
lead

TransMedics

INDUSTRY

NCT03868904 - INSPIRE Continuation Post-Approval Study | Biotech Hunter | Biotech Hunter